Polaryx Therapeutics, Inc. (PLYX)
Market Closed
10 Aug, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
2. 12
-0.14
-6.1947%
$
109.16M Market Cap
- P/E Ratio
- Div Yield
131,428 Volume
- Eps
$ 2.26
Previous Close 
Want to track PLYX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Polaryx Therapeutics, Inc. (PLYX) Statistics
Valuation metrics
Market Cap 109.16M
Enterprise value 109.57M
Trailing P/E (ttm) -22.97
Forward P/E -
PEG ratio 0.28
Price/Sales (ttm) -
Price/Book (mrq) 42.89
Enterprise Value/Revenue -
Enterprise Value/EBITDA -16.92
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 69.21K
Average volume (90 days) 177.71K
Price summary
52-Week low 1.86
52-Week high 48.91
Beta -
50-Day moving average 2.42
200-Day moving average 4.63
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.85%
Return on equity -1.66%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.14
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.07
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 3.45%
Book value per share (mrq) 0.05
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
